Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.35% |
| 2 | Consumer Staples | 2.31% |
| 3 | Technology | 1.26% |
| 4 | Financials | 1.12% |
| 5 | Healthcare | 1.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
Fidelity MSCI Health Care Index ETF
FHLC
$3.47B
| $2M | ﹤0.01% |
+58,107
| New | +$2.03M |
|
3552
CALL
ManpowerGroup
MAN
$2.9B
| $2M | ﹤0.01% |
27,700
-6,500
| -19% | -$448K |
|
3553
CALL
Trex
TREX
$4.66B
| $2M | ﹤0.01% |
136,400
+94,000
| +222% | +$1.31M |
|
3554
CALL
Apollo Global Management
APO
$79.7B
| $2M | ﹤0.01% |
111,300
-117,700
| -51% | -$2.06M |
|
3555
PUT
Buckle
BKE
$2.24B
| $2M | ﹤0.01% |
83,200
+43,400
| +109% | +$1.12M |
|
3556
CALL
Acadia Healthcare
ACHC
$2.66B
| $2M | ﹤0.01% |
40,300
-222,900
| -85% | -$11.6M |
|
3557
MSC Industrial Direct
MSM
$6.66B
| $2M | ﹤0.01% |
27,200
+17,300
| +175% | +$1.26M |
|
|
ODP
3558
PUT
DELISTED
ODP
ODP
| $2M | ﹤0.01% |
55,930
-20,780
| -27% | -$737K |
|
3559
PUT
Public Service Enterprise Group
PEG
$36.5B
| $2M | ﹤0.01% |
47,700
+39,700
| +496% | +$1.75M |
|
|
SDRL
3560
CALL
DELISTED
Seadrill Limited Common Stock
SDRL
| $2M | ﹤0.01% |
3,144
-2,860
| -48% | -$2.05M |
|
3561
Danaher
DHR
$152B
| $1.99M | ﹤0.01% |
28,675
-9,147
| -24% | -$648K |
|
|
MBT
3562
PUT
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $1.99M | ﹤0.01% |
261,200
+15,800
| +6% | +$134K |
|
3563
CALL
MannKind Corp
MNKD
$1.27B
| $1.99M | ﹤0.01% |
641,020
-495,900
| -44% | -$2.19M |
|
|
FHK
3564
DELISTED
First Trust Hong Kong AlphaDEX Fund
FHK
| $1.98M | ﹤0.01% |
55,037
+30,181
| +121% | +$1.05M |
|
3565
CALL
Xerox
XRX
$402M
| $1.98M | ﹤0.01% |
74,306
-22,732
| -23% | -$587K |
|
3566
CALL
Prosperity Bancshares
PB
$8.69B
| $1.98M | ﹤0.01% |
36,100
-20,000
| -36% | -$1.06M |
|
3567
CALL
Live Nation Entertainment
LYV
$42.3B
| $1.98M | ﹤0.01% |
72,100
-44,300
| -38% | -$1.16M |
|
|
QVCGA
3568
DELISTED
QVC Group Inc Series A
QVCGA
| $1.98M | ﹤0.01% |
+2,039
| New | +$2.25M |
|
3569
CALL
Lincoln Electric
LECO
$15.5B
| $1.98M | ﹤0.01% |
31,600
+3,300
| +12% | +$205K |
|
3570
CALL
Neogen
NEOG
$2.54B
| $1.98M | ﹤0.01% |
94,133
-8,000
| -8% | -$171K |
|
3571
CALL
Myriad Genetics
MYGN
$302M
| $1.97M | ﹤0.01% |
95,900
+19,700
| +26% | +$500K |
|
3572
PUT
OSI Systems
OSIS
$3.29B
| $1.97M | ﹤0.01% |
30,200
-7,000
| -19% | -$441K |
|
3573
PUT
Immersion
IMMR
$254M
| $1.97M | ﹤0.01% |
241,700
+107,500
| +80% | +$796K |
|
3574
CALL
UDR
UDR
$11.9B
| $1.97M | ﹤0.01% |
54,800
+39,000
| +247% | +$1.42M |
|
|
ARRS
3575
CALL
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $1.97M | ﹤0.01% |
69,600
+37,200
| +115% | +$994K |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q3 2016 filing shows 1,347 new, 3,278 increased, 3,435 reduced and 1,488 closed positions. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M. The largest sale was Apple, an estimated $762M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 93% a quarter earlier, followed by Consumer Staples and Technology.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.